Over the next half century or so, the purified insulins obtained from pig or cow pancreases were constantly improved in purity and formulated in ways that refined their performance.
Over many years the FDA had had prodigious experience with insulins and with drugs derived from various microorganisms, so it was decided that no fundamentally new regulatory paradigms were necessary to evaluate the recombinant human insulin.
But Aventis will continue to face stiff competition in the diabetes market from major players such as Eli Lilly (nyse: LLY - news - people ), which has an impressive portfolio of insulins, and Bristol-Myers Squibb (nyse: BMY - news - people ), which makes many of the pills that are used in treating adult diabetes.